iCo Therapeutics Inc. Announces Year End 2013 Financial Results

... latent HIV reservoirs which remain in individuals despite enormous therapeutic advances in the treatment of HIV/AIDS. Announced the final month eight patient visit in the Phase 2 iDEAL Study evaluating the efficacy and safety of iCo-007 after ...

http://ift.tt/1pyXX5l